Johnson & Johnson to compensate $4.7bn indemnification in talc cancer case

Johnson  Johnson baby powderImage copyright
Getty Images

Image caption

Johnson Johnson pronounced a reserve of a talcum powder is upheld by decades of systematic evidence

Johnson Johnson has been systematic to compensate $4.7bn (£3.6bn) in indemnification to 22 women who purported that a talc products caused them to rise ovarian cancer.

A jury in a US state of Missouri primarily awarded $550m in remuneration and combined $4.1bn in punitive damages.

The outcome comes as a curative hulk battles some 9,000 authorised cases involving a signature talcum powder.

JJ pronounced it was “deeply disappointed” and skeleton to appeal.

In a 6 week trial, a women and their families pronounced they grown ovarian cancer after regulating baby powder and other talc products for decades.

Their lawyers purported a association knew a talcum powder was infested with asbestos given a 1970s though unsuccessful to advise consumers about a risks.

The association denied that a products ever contained asbestos and insisted that they do not means cancer.

The curative hulk combined that several studies have shown a talcum powder to be protected and insisted a outcome was a product of a “fundamentally astray process”.

Record outcome

The outcome is a largest payout JJ has faced over allegations a talc products means cancer.

A prior statute in 2017 by a California jury awarded $417m (£323.4m) to a lady who pronounced she grown ovarian cancer after regulating a firm’s products including baby powder.

However, a decider after overturned that outcome and several other authorised hurdles by JJ are nonetheless to be decided.

Punitive indemnification are mostly reduced by a hearing decider or on appeal, and JJ has succeeded in carrying several jury verdicts overturned, some of them on technical grounds.